Skip to main content
. Author manuscript; available in PMC: 2011 Aug 1.
Published in final edited form as: J Neuroendocrinol. 2010 Apr 23;22(8):936–943. doi: 10.1111/j.1365-2826.2010.02009.x

Fig. 3.

Fig. 3

Nuclear TOP-immunoreactivity in the ventrolateral portion of the ventromedial hypothalamic nucleus (VMNvl) from females treated with A) vehicle or B) estradiol benzoate (2 ug). Images were taken at 400× magnification (bars = 20 μm).